PDLI Operating Income Growth
Pdl Biopharma Inc · Operating Income Growth
PDLI Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-100.00%period ending
PDLI Quarterly Operating Income YoY % (44.07% → -100.00%)
Year-over-year change
High-resolution chart · PNG
PDLI operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -100% | |
| 79.5969% | |
| -225.5205% | |
| -263.0609% | |
| -73.9783% | |
| -1,255.9518% | |
| 255.7594% | |
| -14.1007% | |
| 33.073% | |
| -96.0213% | |
| -79.6894% | |
| -27.3016% | |
| 2.1731% | |
| 1,507.0931% | |
| -82.8142% | |
| -77.2657% | |
| -75.0728% | |
| -94.4498% | |
| -35.8858% | |
| 83.423% | |
| -26.5785% | |
| -15.0455% | |
| 6.7844% | |
| -10.9224% | |
| 63.1431% | |
| 4.6662% | |
| 45.4637% | |
| 23.4071% | |
| 12.3203% | |
| 13.3116% | |
| 18.4766% | |
| 14.2086% | |
| -0.9287% | |
| 1.5925% | |
| -8.4611% | |
| 341.2179% | |
| 6.6346% | |
| 6.5843% | |
| 48.265% | |
| -153.9146% | |
| 13.81% | |
| -7.2759% | |
| -9.1112% | |
| -61.9691% | |
| 370.0064% | |
| 120.0886% | |
| 63.8495% | |
| 947.381% | |
| 584.7849% | |
| 260.7367% | |
| 434.1367% | |
| 81.9725% | |
| 44.6561% | |
| 352.2311% | |
| 59.9644% | |
| -322.062% | |
| 85.8235% | |
| -138.4279% | |
| -403.5054% | |
| -34.4442% | |
| -143.496% | |
| 81.5809% | |
| 61.029% | |
| 11.9176% | |
| 23.4957% | |
| -84.5614% | |
| -1,148.1712% | |
| -74.4452% | |
| -59.0207% | |
| -55.2808% | |
| -68.8182% | |
| -235.3415% | |
| -2,748.0932% | |
| -188.5343% | |
| -53.5871% | |
| 63.6406% | |
| 106.1053% | |
| 92.02% | |
| 924.4197% | |
| -6.7125% | |
| -306.8947% | |
| 156.14% | |
| 74.3571% | |
| -5.2632% | |
| -26.6667% | |
| -47.0588% | |
| 34.375% | |
| -15.1515% | |
| 54.5455% | |
| 37.037% | |
| -12.2807% | |
| -100% | |
| 44.0678% |